EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage

Renske Linstra, Chantal Stappenbelt, Femke J Bakker, Marieke Everts, Arkajyoti Bhattacharya, Shibo Yu, Stella D van Bergen, Bert van der Vegt, G Bea A Wisman, Rudolf S N Fehrmann, Marco de Bruyn, Marcel A T M van Vugt

Journal of Biological Chemistry · 2025-06 · 301 (6) · 108560

DOI: 10.1016/j.jbc.2025.108560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-06. Verfasst von Renske Linstra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, DNA Damage, Membrane Proteins, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Universiteit Utrecht, Dutch Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amplification of the MYC proto-oncogene is frequently observed in various cancer types, including triple-negative breast cancer (TNBC). Emerging evidence suggests that suppression of local antitumor immune responses by MYC, at least in part, explains the tumor-promoting effects of MYC. Specifically, MYC upregulation was demonstrated to suppress the tumor-cell intrinsic activation of a type I interferon response and thereby hamper innate inflammatory signaling, which may contribute to the disappointing response to immunotherapy in patients with TNBC. In this study, we show that MYC interferes with protein expression and functionality of the STING pathway. MYC-mediated STING downregulation in BT-549 and MDA-MB-231 TNBC cell lines requires the DNA-binding ability of MYC and is independent of binding of MYC to its co-repressor MIZ1. Both STAT1 and STAT3 promote the steady-state expression levels of STING, and STAT3 cooperates with MYC in regulating STING. Conversely, MYC-mediated downregulation of STING affects protein levels of STAT1 and downstream chemokine production. Furthermore, we show that MYC overexpression hampers immune cell activation triggered by DNA damage through etoposide or irradiation treatment and specifically impedes the activation of natural killer cells. Collectively, these results show that MYC controls STING levels and thereby regulates tumor cell-intrinsic inflammatory signaling. These results contribute to our understanding of how MYC suppresses inflammatory signaling in TNBC and may explain why a large fraction of patients with TNBC do not benefit from immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycDNA DamageMembrane ProteinsSignal TransductionTriple Negative Breast NeoplasmsHumansProto-Oncogene MasFemaleSTAT1 Transcription FactorCell Line, TumorDown-RegulationSTAT3 Transcription FactorGene Expression Regulation, NeoplasticInflammationSTING Protein

Stichwörter der Autor:innen

Myc (c-MYC)breast cancerinnate immunityinterferontranscription regulationtumor immunology

Substanzen

Proto-Oncogene Proteins c-mycProto-Oncogene MasMembrane ProteinsSTAT1 Transcription FactorSTAT3 Transcription FactorSTING1 protein, humanSTING ProteinMAS1 protein, humanMYC protein, humanSTAT1 protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: m.vugt@umcg.nl.

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Universiteit Utrecht
  • Dutch Cancer Society

Zitieren

APA

Linstra, R., Stappenbelt, C., Bakker, F. J., Everts, M., Bhattacharya, A., Yu, S., van Bergen, S. D., van der Vegt, B., Wisman, G. B. A., Fehrmann, R. S. N., de Bruyn, M., & van Vugt, M. A. T. M. (2025). MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage. Journal of Biological Chemistry, 301(6), 108560. https://doi.org/10.1016/j.jbc.2025.108560

Vancouver

Linstra R, Stappenbelt C, Bakker FJ, Everts M, Bhattacharya A, Yu S, et al. MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage. Journal of Biological Chemistry. 2025;301(6):108560. doi:10.1016/j.jbc.2025.108560

BibTeX
@article{Linstra2025,
  author = {Linstra, Renske and Stappenbelt, Chantal and Bakker, Femke J and Everts, Marieke and Bhattacharya, Arkajyoti and Yu, Shibo and van Bergen, Stella D and van der Vegt, Bert and Wisman, G Bea A and Fehrmann, Rudolf S N and de Bruyn, Marco and van Vugt, Marcel A T M},
  title = {MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {6},
  pages = {108560},
  doi = {10.1016/j.jbc.2025.108560}
}
Kostenlos starten →